Biologic survival: a novel approach for drug efficacy estimation in psoriasis
Br J Dermatol
.
2024 Apr 17;190(5):612-613.
doi: 10.1093/bjd/ljae007.
Authors
Qinmengge Li
1
2
,
Lam C Tsoi
1
2
3
Affiliations
1
Department of Dermatology.
2
Department of Biostatistics.
3
Department of Computational Medicine and Bioinformatics, Mary H. Weiser Food Allergy Center, University of Michigan, Ann Arbor, MI, USA.
PMID:
38174815
PMCID:
PMC11023616
(available on
2025-01-04
)
DOI:
10.1093/bjd/ljae007
No abstract available
Publication types
Editorial
Comment
MeSH terms
Biological Factors
Biological Products*
Cohort Studies
Dermatologists
HLA-C Antigens
Humans
Immunologic Factors
Psoriasis*
Substances
HLA-C Antigens
Biological Factors
Immunologic Factors
Biological Products
Grants and funding
R01 AR080662/AR/NIAMS NIH HHS/United States
K01AR072129/GF/NIH HHS/United States